A Medicare utilization surge in the fourth quarter of 2024 is clouding the health insurance industry's outlook in 2024, according to an April 8 report from Fitch Ratings shared with Becker's.
Payer
Blue Cross Blue Shield of Massachusetts is increasing reimbursement rates to qualifying small, independent primary care practices.
Clover Health CEO Andrew Toy feels good about CMS' 2025 Medicare Advantage rates.
CareFirst BlueCross BlueShield is offering space in its Baltimore headquarters for Small Business Administration employees assisting business owners in the wake of the Francis Scott Key Bridge collapse.
Medicare Advantage plans saw utilization rates rise 8.1% in the fourth quarter of 2023, primarily driven by outpatient and emergency room services, according to an AHIP survey.
Advertisement
The parent company of Harvard Pilgrim Health Care and Tufts Health Plan is updating prior authorization for home health services as it conducts a larger review of its requirements.
From Vanguard Group acquiring the sale of its scrapped East Coast campus, to completing the sale of its U.K. companies, here are eight updates on Centene that Becker's has reported since Feb. 6:
Investment income drove a $377 million net income for Independence Blue Cross in 2023.
Investment advisory firm Vanguard Group is acquiring the Charlotte, N.C.-based office campus that was once planned to be Centene's East Coast headquarters, the Charlotte Business Journal reported April 2.
Medicare total spending hit $5.7 billion in 2022 after rebates for GLP-1 drugs such as Ozempic, Wegovy and Mounjaro, up from $57 million in 2018, according to a March 22 KFF analysis.